The Impact of Positron Emission Tomography on Clinical Decision Making in a University-Based Multidisciplinary Lung Cancer Practice
- 1 August 2005
- journal article
- Published by Elsevier BV in Chest
- Vol. 128 (2), 698-703
- https://doi.org/10.1378/chest.128.2.698
Abstract
No abstract availableKeywords
This publication has 21 references indexed in Scilit:
- PET and SPECT in the management of lung cancerCurrent Opinion in Pulmonary Medicine, 2002
- T1 Lung Cancers: Sensitivity of Diagnosis with Fluorodeoxyglucose PETRadiology, 2002
- Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non-small-cell lung cancer: the PLUS multicentre randomised trialThe Lancet, 2002
- FDG-PET imaging in the management of non-small-cell lung cancerAnnals Of Oncology, 2002
- POSITRON EMISSION TOMOGRAPHY IMAGING IN THE THORAXClinics in Chest Medicine, 1999
- Analytical decision model for the cost-effective management of solitary pulmonary nodules.Journal of Clinical Oncology, 1998
- Lymph node staging in non-small-cell lung cancer with FDG-PET scan: a prospective study on 690 lymph node stations from 68 patients.Journal of Clinical Oncology, 1998
- Prospective investigation of positron emission tomography in lung nodules.Journal of Clinical Oncology, 1998
- Non-small cell lung cancer: nodal staging with FDG PET versus CT with correlative lymph node mapping and sampling.Radiology, 1997
- Staging non—small cell lung cancer by whole-body positron emission tomographic imagingThe Annals of Thoracic Surgery, 1995